Casdin Capital LLC 13D and 13G filings for BioLife Solutions, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-17 8:04 pm Sale | 2025-10-15 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital LLC | 5,957,165 12.400% | -750,000 (-11.18%) | Filing |
| 2025-08-21 9:35 pm Sale | 2025-08-15 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital LLC | 6,707,165 14.000% | -500,000 (-6.94%) | Filing |
| 2025-08-13 7:00 pm Sale | 2025-08-11 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital LLC | 7,207,165 15.000% | -500,000 (-6.49%) | Filing |
| 2025-06-12 9:10 pm Sale | 2025-06-10 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital LLC | 7,707,165 16.200% | -1,027,994 (-11.77%) | Filing |
| 2025-04-09 5:13 pm Purchase | 2025-04-07 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital LLC | 8,735,159 18.500% | 27,994 (+0.32%) | Filing |
| 2023-10-24 4:29 pm Purchase | 2023-10-19 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital LLC | 8,707,165 19.500% | 1,267,058 (+17.03%) | Filing |
| 2021-02-11 10:25 am Purchase | 2020-12-31 | 13G | BioLife Solutions, Inc. BLFS | Casdin Capital LLC | 3,346,035 6.930% | 247,913 (+8.00%) | Filing |
| 2021-02-11 10:19 am Purchase | 2020-12-31 | 13G | BioLife Solutions, Inc. BLFS | Casdin Capital LLC | 12,298,038 6.370% | 3,264,095 (+36.13%) | Filing |